Apyx Medical (APYX) Long-Term Deferred Tax (2010 - 2016)

Apyx Medical (APYX) has reported Long-Term Deferred Tax for 7 consecutive years, with $21000.0 the latest figure, recorded in Q2 2016.

• For the quarter ending Q2 2016, Long-Term Deferred Tax changed N/A year-over-year to $21000.0; the trailing twelve-month figure through Jun 2016 stood at $21000.0 (changed N/A YoY), and the FY2015 full-year result was $25000.0, down 99.54% from the prior year.
• Long-Term Deferred Tax eased to $21000.0 in Q2 2016 per APYX's latest filing, from $39000.0 in the prior quarter.
• Across five years, Long-Term Deferred Tax topped out at $5.4 million in Q4 2014 and bottomed at $21000.0 in Q2 2016.
• Historically, Long-Term Deferred Tax has averaged $2.1 million across 5 years, with a median of $1.4 million in 2012.
• The sharpest annual moves came in 2014 and 2015: Long-Term Deferred Tax jumped 58.44% in 2014, then sank 99.54% in 2015.
• Over 5 years, Long-Term Deferred Tax stood at $2.5 million in 2012, then jumped by 35.5% to $3.4 million in 2013, then surged by 58.44% to $5.4 million in 2014, then tumbled by 99.54% to $25000.0 in 2015, then decreased by 16.0% to $21000.0 in 2016.
• According to Business Quant data, Long-Term Deferred Tax over the past three periods registered $21000.0, $39000.0, and $25000.0 for Q2 2016, Q1 2016, and Q4 2015 respectively.